Table 2.
Antitubercular activity in MIC in μM (μg/mL) of compounds 8a–p
| Compound | R | R1 | M. tuberculosis, H37 RV |
|---|---|---|---|
| 8a | H | Methyl | 14.4 (3.12) |
| 8b | H | Ethyl | 27.1 (6.25) |
| 8c | H | n-Propyl | 102 (25) |
| 8d | H | n-Butyl | 24.1 (6.25) |
| 8e | Br | Methyl | 21.2 (6.25) |
| 8f | Br | Ethyl | 20.2 (6.25) |
| 8g | Br | n-Propyl | 19.3 (6.25) |
| 8h | Br | n-Butyl | 9.2 (3.12) |
| 8i | Cl | Methyl | 24.9 (6.25) |
| 8j | Cl | Ethyl | 47.2 (12.5) |
| 8k | Cl | n-Propyl | 22.4 (6.25) |
| 8l | Cl | n-Butyl | 42.7 (12.5) |
| 8m | F | Methyl | 106.4 (25) |
| 8n | F | Ethyl | 401.6 (100) |
| 8o | F | n-Propyl | 190.1 (50) |
| 8p | F | n-Butyl | 180.5 (50) |
| Pyrazinamide | 25.34 (3.12) | ||
| Isoniazid | 11.67 (1.6) | ||